Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Renal Cell Carcinoma × balstilimab × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 10 Stomach Neoplasms 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Neoplasms 2 Neoplasm Metastasis 2 Colonic Neoplasms 2 Uterine Cervical Neoplasms 1 Sarcoma 1 Resectable MMR-deficient Solid Tumors 1 Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) 1 Pancreatic Cancer Metastatic 1 Oropharyngeal Neoplasms 1 Microsatellite Stable Rectal Carcinoma 1 Lymphoma 1 Glioma 1 Esophageal Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Cancer Metastatic 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Advanced Solid Tumor 1 Advanced Renal Cell Carcinoma 1 Adenocarcinoma Of Esophagus 1 Adenocarcinoma 1

Interventions

balstilimab 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05928806 2026-02-11

ARCITECT

Hoosier Cancer Research Network

Phase 2 Suspended

Advanced Renal Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡